MDM2 and neoplasm: Additionally, the MDM2 inhibitor Nutlin-3 was found to enhance antitumor responses of MDM2-specific T cells by upregulating human leukocyte antigen (HLA) class II expression on tumor cells with the aid of CD4 + T cells [39].